Institution
Emory Healthcare
Healthcare•Atlanta, Georgia, United States•
About: Emory Healthcare is a healthcare organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Health care & Population. The organization has 654 authors who have published 655 publications receiving 17390 citations.
Topics: Health care, Population, Cancer, Medicine, Prostate cancer
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A 5-year, double-blind, randomized, placebo-controlled study was conducted to determine whether salmon calcitonin nasal spray reduced the risk of new vertebral fractures in postmenopausal women with osteoporosis.
1,026 citations
••
TL;DR: A revised taxonomic system for disorders previously called reflex sympathetic dystrophy (RSD) and causalgia is presented and these revised categories have been included in the 2nd edition of the IASP Classification of Chronic Pain Syndromes.
Abstract: We present a revised taxonomic system for disorders previously called reflex sympathetic dystrophy (RSD) and causalgia. The system resulted from a special consensus conference that was convened on this topic and is based upon the patient's history, presenting symptoms, and findings at the time of diagnosis. The disorders are grouped under the umbrella term CRPS: complex regional pain syndrome. This overall term, CRPS, requires the presence of regional pain and sensory changes following a noxious event. Further, the pain is associated with findings such as abnormal skin color, temperature change, abnormal sudomotor activity, or edema. The combination of these findings exceeds their expected magnitude in response to known physical damage during and following the inciting event. Two types of CRPS have been recognized: type I, corresponds to RSD and occurs without a definable nerve lesion, and type II, formerly called causalgia refers to cases where a definable nerve lesion is present. The term sympathetically maintained pain (SMP) was also evaluated and considered to be a variable phenomenon associated with a variety of disorders, including CRPS types I and II. These revised categories have been included in the 2nd edition of the IASP Classification of Chronic Pain Syndromes.
1,025 citations
••
TL;DR: Key challenges to providing high-quality care as patients leave the hospital are reviewed, including the discontinuity between hospitalists and primary care physicians, changes to the medication regimen, new self-care responsibilities that may stress available resources, and complex discharge instructions.
Abstract: The period following discharge from the hospital is a vulnerable time for patients. About half of adults experience a medical error after hospital discharge, and 19%-23% suffer an adverse event, most commonly an adverse drug event. This article reviews several important challenges to providing high-quality care as patients leave the hospital. These include the discontinuity between hospitalists and primary care physicians, changes to the medication regimen, new self-care responsibilities that may stress available resources, and complex discharge instructions. We also discuss approaches to promoting more effective transitions of care, including improvements in communication between inpatient and outpatient physicians, effective reconciliation of prescribed medication regimens, adequate education of patients about medication use, closer medical follow-up, engagement with social support systems, and greater clarity in physician-patient communication. By understanding the key challenges and adopting strategies to improve patient care in the transition from hospital to home, hospitalists could significantly reduce medical errors in the postdischarge period.
738 citations
••
TL;DR: Using data available in the ICU in real-time, Artificial Intelligence Sepsis Expert can accurately predict the onset of sepsis in an ICU patient 4–12 hours prior to clinical recognition.
Abstract: OBJECTIVE
Sepsis is among the leading causes of morbidity, mortality, and cost overruns in critically ill patients. Early intervention with antibiotics improves survival in septic patients. However, no clinically validated system exists for real-time prediction of sepsis onset. We aimed to develop and validate an Artificial Intelligence Sepsis Expert (AISE) algorithm for early prediction of sepsis.
471 citations
••
TL;DR: A broad spectrum of renal cell tumors exist in ESRD, only some of which resemble the sporadic RCCs, and only the acquired cystic disease-associated RCC appears to be more aggressive than the other tumor subtypes in E SRD.
Abstract: Most (up to 71%) of renal cell neoplasms occurring in patients with end-stage renal disease (ESRD), particularly with acquired cystic disease of the kidney (ACDK), have been reported to be papillary renal cell carcinoma (RCC). Our initial experience with tumors in such a setting indicated that many tumors were histologically difficult to classify into the known subtypes of RCC or had features that were different from those in sporadically occurring RCCs. In this study on 66 ESRD kidneys (52 of which showed features of ACDK) removed because tumors were detected in them, we found two major groups of RCC. Overall, there were 261 grossly identified tumors in these kidneys, and many additional tumors were observed on microscopic evaluation in some. Of the two major groups of RCCs, one consisted of tumors similar to those seen in sporadic settings (ie, clear-cell, papillary, and chromophobe RCC), and these formed the dominant mass in 12 (18%), 10 (15%), and 5 (8%) of the 66 kidneys, respectively. The other group consisted of two subtypes of RCC that appear quite unique to ESRD. The more common tumor that we have designated as "acquired cystic disease-associated RCC" was seen as the dominant mass in 24 (36%) of 66 of the kidneys, and it formed the most common tumor type among the smaller nondominant masses, as well. It was characterized by a typical microcystic architecture, eosinophilic cytoplasm with Fuhrman's grade 3 nuclei, and frequent association with intratumoral oxalate crystals. Additionally, these tumors frequently, but usually focally, exhibited papillary architecture, and clear cytoplasm. These tumors occurred only in kidneys with ACDK, and not in noncystic ESRD. The other category was "clear-cell papillary RCC of the end-stage kidneys," present as the dominant mass in 15 (23%) of the 66 kidneys and occurring in both the ACDK and noncystic ESRD. These predominantly cystic tumors showed prominent papillary architecture with purely clear-cell cytology. Immunohistochemical studies in tumors with histology similar to the known subtypes of sporadic RCC showed immunoprofiles similar to that reported in sporadically occurring tumors. The two subtypes of RCC unique to ESRD had distinctive immunoprofiles supporting their separate morphologic subcategorization. Only the acquired cystic disease-associated RCC showed lymph node metastases in 2 cases and sarcomatoid features in 2 more cases. One of the latter 2 died with widespread metastatic disease within 34 months of nephrectomy. Thus, a broad spectrum of renal cell tumors exist in ESRD, only some of which resemble the sporadic RCCs. Acquired cystic disease-associated RCC is the commonest tumor subtype in ESRD, and biologically it appears to be more aggressive than the other tumor subtypes in ESRD.
415 citations
Authors
Showing all 660 results
Name | H-index | Papers | Citations |
---|---|---|---|
Delos M. Cosgrove | 101 | 355 | 34085 |
Barbara O. Rothbaum | 84 | 344 | 31321 |
Mahul B. Amin | 82 | 303 | 20189 |
Jerrold H. Levy | 79 | 509 | 24864 |
Stuart J. Knechtle | 69 | 428 | 18289 |
David Howard | 69 | 366 | 16683 |
Michael J. Lynn | 65 | 234 | 16507 |
Philip A. Starr | 64 | 245 | 14758 |
Shi-Yong Sun | 64 | 205 | 19137 |
Vin Tangpricha | 64 | 301 | 15767 |
Donald L. Bliwise | 63 | 347 | 15687 |
Valérie Biousse | 61 | 333 | 12021 |
Roy A.E. Bakay | 60 | 204 | 15455 |
Stewart A. Factor | 60 | 228 | 13393 |
Timothy G. Buchman | 60 | 267 | 14752 |